The milestones in xenotransplantation – cross-species transplants – rely on cutting-edge biotechnologies, including the use ...
The discovery by the UK Health Security Agency (UKHSA) raises the possibility that viral diseases that are known to be ...
Editor's Note: pharmaphorum is an editorially independent publication owned by EVERSANA.
Ionis' antisense therapy Zanvastro has been approved by the FDA for Alexander disease (AxD), throwing a lifeline to people ...
Interim data from the 393-patient phase 3 CERVINO trial of etentamig (ABBV-383), a bispecific CD3 and BCMA-directed TCE, ...
Shares in the UK's IP Group slid today after it revealed that an arthritis drug in development at one of its portfolio companies, Istesso, had failed a phase 2b trial. The early-stage investor in life ...
Denmark's Netcompany has been awarded a five-year contract from NHS England, worth more than £215 million, to build the ...
PMV Pharma is preparing to file for approval of its oral p53 protein reactivator drug rezatopopt in the first quarter of 2027 ...
The US Advanced Research Projects Agency for Health (ARPA-H) has awarded $125 million in funding, split across five groups, ...
Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in relapsing multiple sclerosis (RMS ...
The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...
The US FDA issued similar warning letters to five different online peptide vendors on 24th August, giving the companies 15 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results